These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Treatment of homozygous familial hypercholesterolemia with low density lipoprotein apheresis: a 4 year follow-up study. Fadul JE; Vessby B; Wikström B; Danielson BG Artif Organs; 1997 May; 21(5):364-8. PubMed ID: 9129767 [TBL] [Abstract][Full Text] [Related]
8. LDL apheresis in clinical practice: long-term treatment of severe hyperlipidemia. Bambauer R; Schiel R; Latza R; Klinkmann J; Schneidewind JM Ther Apher; 1997 Feb; 1(1):49-54. PubMed ID: 10225781 [TBL] [Abstract][Full Text] [Related]
9. LDL-apheresis as long-term treatment in severe hyperlipidemia using differing methods. Bambauer R; Schiel R; Latza R; Schneidewind JM ASAIO J; 1999; 45(5):408-12. PubMed ID: 10503616 [TBL] [Abstract][Full Text] [Related]
10. Low density lipoprotein apheresis in treatment of hyperlipidemia: experience with four different technologies. Bambauer R; Schiel R; Latza R Ther Apher; 2000 Jun; 4(3):213-7. PubMed ID: 10910023 [TBL] [Abstract][Full Text] [Related]
11. Low-density lipoprotein apheresis: clinical results with different methods. Bambauer R Artif Organs; 2002 Feb; 26(2):133-9. PubMed ID: 11879241 [TBL] [Abstract][Full Text] [Related]
12. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia. Richter WO; Donner MG; Höfling B; Schwandt P Metabolism; 1998 Jul; 47(7):863-8. PubMed ID: 9667236 [TBL] [Abstract][Full Text] [Related]
13. Long-term lipoprotein apheresis in the treatment of severe familial hypercholesterolemia refractory to high intensity statin therapy: Three year experience at a lipoprotein apheresis centre. Mickiewicz A; Borowiec-Wolna J; Bachorski W; Gilis-Malinowska N; Gałąska R; Raczak G; Chmara M; Wasąg B; Jaguszewski MJ; Fijałkowski M; Gruchała M Cardiol J; 2019; 26(6):669-679. PubMed ID: 30234904 [TBL] [Abstract][Full Text] [Related]
14. Low-density lipoprotein apheresis for prevention and regression of atherosclerosis: clinical results. Bambauer R; Olbricht CJ; Schoeppe E Ther Apher; 1997 Aug; 1(3):242-8. PubMed ID: 10225746 [TBL] [Abstract][Full Text] [Related]
15. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia. Lee WP; Datta BN; Ong BB; Rees A; Halcox J Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315 [TBL] [Abstract][Full Text] [Related]
16. Effects of LDL apheresis on restenosis after angioplasty. Kanemitsu S; Tekekoshi N; Murakami E Chem Phys Lipids; 1994 Jan; 67-68():339-43. PubMed ID: 8187232 [TBL] [Abstract][Full Text] [Related]
17. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels. Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321 [TBL] [Abstract][Full Text] [Related]
18. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia. Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647 [TBL] [Abstract][Full Text] [Related]
19. Effect of specific lipoprotein(a) apheresis on coronary atherosclerosis regression assessed by quantitative coronary angiography. Safarova MS; Ezhov MV; Afanasieva OI; Matchin YG; Atanesyan RV; Adamova IY; Utkina EA; Konovalov GA; Pokrovsky SN Atheroscler Suppl; 2013 Jan; 14(1):93-9. PubMed ID: 23357149 [TBL] [Abstract][Full Text] [Related]
20. Short- and long-term effects on serum lipoproteins by three different techniques of apheresis. Richter WO; Donner MG; Schwandt P Artif Organs; 1996 Apr; 20(4):311-7. PubMed ID: 8860712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]